125 related articles for article (PubMed ID: 21264782)
41. Endocrine aspects of bone metastases.
Hofbauer LC; Rachner TD; Coleman RE; Jakob F
Lancet Diabetes Endocrinol; 2014 Jun; 2(6):500-12. PubMed ID: 24880565
[TBL] [Abstract][Full Text] [Related]
42. Molecular biology of bone metastasis.
Kingsley LA; Fournier PG; Chirgwin JM; Guise TA
Mol Cancer Ther; 2007 Oct; 6(10):2609-17. PubMed ID: 17938257
[TBL] [Abstract][Full Text] [Related]
43. Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer.
Rentsch CA; Cecchini MG; Thalmann GN
Swiss Med Wkly; 2009 Apr; 139(15-16):220-5. PubMed ID: 19418305
[TBL] [Abstract][Full Text] [Related]
44. Bone metastasis in breast cancer: the role of parathyroid hormone related protein.
Iddon J; Byrne G; Bundred NJ
Surg Oncol; 1999 Jul; 8(1):13-25. PubMed ID: 10885390
[No Abstract] [Full Text] [Related]
45. Interleukin-6 in bone metastasis and cancer progression.
Ara T; Declerck YA
Eur J Cancer; 2010 May; 46(7):1223-31. PubMed ID: 20335016
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone.
Lange PH; Vessella RL
Cancer Metastasis Rev; 1998-1999; 17(4):331-6. PubMed ID: 10453276
[TBL] [Abstract][Full Text] [Related]
47. Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications.
Zheng H; Li W; Kang Y
Cold Spring Harb Symp Quant Biol; 2016; 81():151-161. PubMed ID: 28381439
[TBL] [Abstract][Full Text] [Related]
48. Tumour metastasis as an adaptation of tumour cells to fulfil their phosphorus requirements.
de Carvalho CC; Caramujo MJ
Med Hypotheses; 2012 May; 78(5):664-7. PubMed ID: 22391031
[TBL] [Abstract][Full Text] [Related]
49. On a mathematical model of bone marrow metastatic niche.
Munoz AI; Tello JI
Math Biosci Eng; 2017 Feb; 14(1):289-304. PubMed ID: 27879134
[TBL] [Abstract][Full Text] [Related]
50. Biomechanical forces in the skeleton and their relevance to bone metastasis: biology and engineering considerations.
Lynch ME; Fischbach C
Adv Drug Deliv Rev; 2014 Dec; 79-80():119-34. PubMed ID: 25174311
[TBL] [Abstract][Full Text] [Related]
51. Passing to the limit 2D-1D in a model for metastatic growth.
Benzekry S
J Biol Dyn; 2012; 6 Suppl 1():19-30. PubMed ID: 22873672
[TBL] [Abstract][Full Text] [Related]
52. Mathematical modeling of bone marrow--peripheral blood dynamics in the disease state based on current emerging paradigms, part I.
Afenya EK; Ouifki R; Camara BI; Mundle SD
Math Biosci; 2016 Apr; 274():83-93. PubMed ID: 26877072
[TBL] [Abstract][Full Text] [Related]
53. Bone lesions in malignant diseases--I. Current concepts of major pathogenetic mechanisms and forms.
Goranov SE; Simeonov SB
Folia Med (Plovdiv); 2002; 44(1-2):7-14. PubMed ID: 12422620
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of cancer metastasis to bone.
Oni OO
J Bone Joint Surg Am; 1987 Feb; 69(2):309-10. PubMed ID: 3805100
[No Abstract] [Full Text] [Related]
55. Analysis of a mathematical model for the growth of cancer cells.
Kohlmann M
Math Med Biol; 2013 Jun; 30(2):175-89. PubMed ID: 22378462
[TBL] [Abstract][Full Text] [Related]
56. [Research progress in the mechanism of bone and bone marrow metastasis in neuroblastoma].
Ren HL; He GQ; Guo X
Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):258-262. PubMed ID: 35240752
[TBL] [Abstract][Full Text] [Related]
57. Influences of Allee effects in the spreading of malignant tumours.
Sewalt L; Harley K; van Heijster P; Balasuriya S
J Theor Biol; 2016 Apr; 394():77-92. PubMed ID: 26802481
[TBL] [Abstract][Full Text] [Related]
58. What's new in musculoskeletal oncology.
Weber KL; Gebhardt MC;
J Bone Joint Surg Am; 2003 Apr; 85(4):761-7. PubMed ID: 12672857
[No Abstract] [Full Text] [Related]
59. Advances in optical imaging and novel model systems for cancer metastasis research.
Henriquez NV; van Overveld PG; Que I; Buijs JT; Bachelier R; Kaijzel EL; Löwik CW; Clezardin P; van der Pluijm G
Clin Exp Metastasis; 2007; 24(8):699-705. PubMed ID: 17972147
[TBL] [Abstract][Full Text] [Related]
60. General perspectives, pathogenesis, pathophysiology, and skeletal dysfunction.
Frassica FJ; Sim FH
Orthopedics; 1992 May; 15(5):599-604. PubMed ID: 1589352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
